The Atrial Fibrillation (AFib) market is currently undergoing substantial expansion, fueled by several converging factors ...
This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...
Current treatments for atrial fibrillation (AFib), a common heart condition characterized by fast and irregular beats that can lead to stroke and heart failure, have multiple side effects and are ...
New research from Cleveland Clinic has identified a link between sleep apnea and the development of atrial fibrillation, a common heart rhythm disorder. Published in JAHA, the study of over 42,000 ...
A recognized link exists between oxidative stress, obesity and atrial fibrillation (AF). NADPH oxidase 2 (NOX2) serves as a significant contributor to reactive oxygen species (ROS) production in the ...
HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...
Philadelphia, March 28, 2024 – Although the vast majority of clinicians do not view atrial fibrillation (AF) as a genetic disorder, a White Paper in the Canadian Journal of Cardiology, published by ...